Stuart Therapeutics Announces Receipt of Study May Proceed Letter from U.S. FDA for ST-100 Dry Eye...
WFMZ Eastern Pennsylvania and Western New Jersey· 2 hours agoSTUART, Fla., April 16, 2021 /PRNewswire/ -- Stuart Therapeutics (Stuart) announced today that the...
Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization For Monoclonal Antibody...
TheStreet.com· 44 minutes agoBased on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2 viral variants that are resistant to bamlanivimab alone resulting in the increased ...
Airway Therapeutics Announces FDA Acceptance Of IND For AT-100's Second Indication In Severe...
TheStreet.com· 5 days agoCINCINNATI, April 12, 2021 /PRNewswire/ -- Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury
Pharma Stock Roundup: JNJ's COVID-19 Vaccine Woes, MRK Ends COVID-19 Drug Development
Zacks via Yahoo Finance· 11 hours agoThis week, the FDA and Centers for Disease Control (“CDC”) jointly recommended pausing immunization...
VTVT Stock: The FDA News Sending vTv Therapeutics Soaring Today
InvestorPlace· 3 days agoToday, investors in vTv Therapeutics (NASDAQ:VTVT) and VTVT stock are certainly happy campers. This...
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference...
Benzinga· 6 days agoContrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. ...
Sorrento’s Subsidiary Scilex Gets FDA Nod For ZTlido Label Expansion
SmarterAnalyst· 4 days agoSorrento Therapeutics’ subsidiary, Scilex Holding, has received approval from the US Food and Drug...
Why Fortress Biotech Stock Is Sinking Today | The Motley Fool
The Motley Fool· 3 days agoEDT, shares of Fortress Biotech were down by 11.3%. Avenue Therapeutics' New Drug Application (NDA)...
New York state ends stem cell research funding
Science· 2 hours agoOver the past decade, New York state has become an international hub of stem cell research. “We are surprised and perplexed,” says Jonathan Teyan, chief...
Timeline for J&J’s vaccine pause grows murkier
Politico· 5 hours agoHHS Secretary Xavier Becerra and acting FDA Commissioner Janet Woodcock said the policy — which would have affected products ranging from sleep assessment ...